Entering text into the input field will update the search result below

Amgen to acquire privately held Teneobio for $900M in cash

Jul. 27, 2021 4:38 PM ETAmgen Inc. (AMGN) StockBy: SA News Team

Amgen(Applied Molecular Genetics Inc.) Capability Center in Tampa.
JHVEPhoto/iStock Editorial via Getty Images

  • Amgen (NASDAQ:AMGN) and Teneobio, a privately held, clinical stage biotechnology company developing a new class of biologics called Human Heavy-Chain Antibodies, announced an agreement wherein the former will acquire the latter.
  • Under agreement terms, Amgen will acquire

Recommended For You

More Trending News

About AMGN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AMGN--
Amgen Inc.